Marta María
Alonso Roldán
Profesional Investigadora
Memorial Sloan Kettering Cancer Center
Nueva York, Estados UnidosPublicaciones en colaboración con investigadores/as de Memorial Sloan Kettering Cancer Center (6)
2024
2023
-
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
Cancer Discovery, Vol. 13, Núm. 11, pp. 2370-2393
-
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial
Nature Medicine, Vol. 29, Núm. 6, pp. 1370-1378
2018
-
Heterogeneity within the PF-EPN-B ependymoma subgroup
Acta Neuropathologica, Vol. 136, Núm. 2, pp. 227-237
2016
-
Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era: A retrospective multicohort analysis
Journal of Clinical Oncology, Vol. 34, Núm. 21, pp. 2468-2477
2013
-
Involvement of miRNAs in the Differentiation of Human Glioblastoma Multiforme Stem-Like Cells
PLoS ONE, Vol. 8, Núm. 10